Clot-busting drugs effective in patients with unwitnessed strokes

February 24, 2010

Clot-busting treatment should be considered for patients last seen healthy within a few hours before having a stroke, according to research presented at the American Stroke Association's International Stroke Conference 2010.

A Canadian study analyzed outcomes of clot-busting drugs given to patients based on when they were last seen in their usual state of health ("time last seen normal") compared to patients who had someone witness the start of their stroke symptoms.

The "time last seen normal" patients did just as well as those with witnessed strokes, having no more disabilities when they were discharged from the hospital and being no more likely to require discharge to a nursing facility. In addition, patients treated based on "time last seen normal" were only 65 percent as likely to have bleeding in the brain -- a potentially serious complication of treatment (7.9 percent vs. 12.1 percent).

"Every 20-minute delay increases the risk of hemorrhage," said Demetrios Sahlas, M.D., M.Sc., FRCPC, the Michael G. DeGroote Professor in Stroke Management at McMaster University in Hamilton, Ontario. "The patients treated based on 'time last seen normal' may have had their strokes minutes or hours after they were last seen, so overall they may have been at lower risk."

Treatment based on "time last seen normal" within the treatment window likely overestimates the time of symptom onset, which suggests that these patients are more likely to experience beneficial outcome, Sahlas said.

When a stroke results from a blood clot in a vessel in or leading to the brain (an ischemic stroke), intravenous medication to dissolve the clot, called recombinant tissue-plasminogen activator (tPA), can limit the debilitating effects. However, after several hours, the likelihood that the drug will improve outcome decreases and the risk it will cause bleeding in the brain and result in greater damage increases.

Traditionally, the time window has been three hours from the time of the stroke. But recent studies -- including randomized trial data from the European Cooperative Acute Stroke Study (ECASS-3) published in 2009 -- suggest that the window could be increased to 4.5 hours for selected patients. The American Stroke Association also changed its recommendation to use tPA up to 4.5 hours in some patients.

In the current study, investigators used the large Registry of the Canadian Stroke Network (RCSN) to compare the outcomes of 1,562 ischemic stroke patients treated at the 11 stroke centers in Ontario between 2003 and 2008. Fifty-one percent were male (average age 72) and 49 percent female (average age 75). Risk factors and the severity of initial symptoms were similar in the 1,082 patients (69 percent) witnessed having a stroke and the 480 (31 percent) treated based on "time last seen normal." Patients with unwitnessed strokes were more likely to be treated greater than 3 hours after "time last seen normal" (27 vs. 12.1 percent).

"If anything, patients identified at the time last seen normal are better candidates for tPA than those in the ECASS trial, which enrolled only those witnessed having a stroke," said Sahlas, who practices at the Central South Ontario Regional Stroke Centre at Hamilton Health Sciences.

Patients in the registry included many who would have been excluded from the ECASS-3 trial because they were over 80 years of age or had previous strokes or diabetes.

"This study provides added justification for extending the window and taking all comers -- not just those witnessed having their strokes," Sahlas said.

"If you come across someone who has had a stroke, act quickly. Be aware that 'time is brain' and seek immediate medical attention. If you last saw someone normal an hour or two ago, that doesn't necessarily disqualify them from receiving tPA."

Researchers who conducted the retrospective study said further prospective research is needed, particularly within the extended time window, to determine whether a difference in clinical outcome is observed.
-end-
Co-authors are Jiming Fang, Ph.D.; Linda Gould, R.P.N.; Linda Kelloway, R.N., B.Sc.N.; Wieslaw Oczkowski, M.D.; and Frank Silver, M.D. Author disclosures are on the abstract.

The study was funded by the Canadian Stroke Network and the Ontario Ministry of Health and Long-Term Care.

Click here to download audio clips offering perspective on this research from American Stroke Association spokesperson, Lee Schwamm, M.D., Vice Chairman, Massachusetts General Hospital, Neurology; Director, Massachusetts General Hospital, Acute Stroke Services; Associate Professor of Neurology, Harvard Medical School; Associate Program Director, MIT General Clinical Research Center; Director, Partners TeleStroke Center, Massachusetts General Hospital; Associate Professor of Neurology, Harvard Med. School, Boston, Mass.

Statements and conclusions of study authors that are presented at American Heart Association/American Stroke Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.

NR10-1010 (ISC 2010/Sahlas)

American Heart Association

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.